ID   PRRT2_HUMAN             Reviewed;         340 AA.
AC   Q7Z6L0; A8K8M8; Q8N2N8; Q8NAQ7; Q8ND36; Q96FA8;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2003, sequence version 1.
DT   07-APR-2021, entry version 140.
DE   RecName: Full=Proline-rich transmembrane protein 2;
DE   AltName: Full=Dispanin subfamily B member 3;
DE            Short=DSPB3;
GN   Name=PRRT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Teratocarcinoma, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Embryo;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-length
RT   human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA
RT   libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH GRIA1 AND SNAP25, SUBCELLULAR LOCATION, AND
RP   CHARACTERIZATION OF VARIANT EKD1 THR-287.
RX   PubMed=25915028; DOI=10.3390/ijms16059134;
RA   Li M., Niu F., Zhu X., Wu X., Shen N., Peng X., Liu Y.;
RT   "PRRT2 Mutant Leads to Dysfunction of Glutamate Signaling.";
RL   Int. J. Mol. Sci. 16:9134-9151(2015).
RN   [7]
RP   INVOLVEMENT IN EKD1, SUBCELLULAR LOCATION, AND VARIANTS ALA-138; HIS-147;
RP   PRO-214; ARG-237 AND HIS-245.
RX   PubMed=22101681; DOI=10.1038/ng.1008;
RA   Chen W.J., Lin Y., Xiong Z.Q., Wei W., Ni W., Tan G.H., Guo S.L., He J.,
RA   Chen Y.F., Zhang Q.J., Li H.F., Lin Y., Murong S.X., Xu J., Wang N.,
RA   Wu Z.Y.;
RT   "Exome sequencing identifies truncating mutations in PRRT2 that cause
RT   paroxysmal kinesigenic dyskinesia.";
RL   Nat. Genet. 43:1252-1255(2011).
RN   [8]
RP   INVOLVEMENT IN BFIS2 AND ICCA, VARIANT ICCA ASN-317, AND VARIANTS ARG-215
RP   AND LEU-216.
RX   PubMed=22243967; DOI=10.1016/j.ajhg.2011.12.003;
RA   Heron S.E., Grinton B.E., Kivity S., Afawi Z., Zuberi S.M., Hughes J.N.,
RA   Pridmore C., Hodgson B.L., Iona X., Sadleir L.G., Pelekanos J.,
RA   Herlenius E., Goldberg-Stern H., Bassan H., Haan E., Korczyn A.D.,
RA   Gardner A.E., Corbett M.A., Gecz J., Thomas P.Q., Mulley J.C.,
RA   Berkovic S.F., Scheffer I.E., Dibbens L.M.;
RT   "PRRT2 mutations cause benign familial infantile epilepsy and infantile
RT   convulsions with choreoathetosis syndrome.";
RL   Am. J. Hum. Genet. 90:152-160(2012).
RN   [9]
RP   INVOLVEMENT IN ICCA, VARIANT ICCA 240-ARG--LYS-340 DEL, INTERACTION WITH
RP   SNAP25, AND SUBCELLULAR LOCATION.
RX   PubMed=22832103; DOI=10.1016/j.celrep.2011.11.001;
RA   Lee H.Y., Huang Y., Bruneau N., Roll P., Roberson E.D., Hermann M.,
RA   Quinn E., Maas J., Edwards R., Ashizawa T., Baykan B., Bhatia K.,
RA   Bressman S., Bruno M.K., Brunt E.R., Caraballo R., Echenne B., Fejerman N.,
RA   Frucht S., Gurnett C.A., Hirsch E., Houlden H., Jankovic J., Lee W.L.,
RA   Lynch D.R., Mohammed S., Mueller U., Nespeca M.P., Renner D., Rochette J.,
RA   Rudolf G., Saiki S., Soong B.W., Swoboda K.J., Tucker S., Wood N.,
RA   Hanna M., Bowcock A.M., Szepetowski P., Fu Y.H., Ptacek L.J.;
RT   "Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with
RT   infantile convulsions.";
RL   Cell Rep. 1:2-12(2012).
RN   [10]
RP   INVOLVEMENT IN BFIS2.
RX   PubMed=22399141; DOI=10.1038/jhg.2012.23;
RA   Ono S., Yoshiura K.I., Kinoshita A., Kikuchi T., Nakane Y., Kato N.,
RA   Sadamatsu M., Konishi T., Nagamitsu S., Matsuura M., Yasuda A., Komine M.,
RA   Kanai K., Inoue T., Osamura T., Saito K., Hirose S., Koide H., Tomita H.,
RA   Ozawa H., Niikawa N., Kurotaki N.;
RT   "Mutations in PRRT2 responsible for paroxysmal kinesigenic dyskinesias also
RT   cause benign familial infantile convulsions.";
RL   J. Hum. Genet. 57:338-341(2012).
RN   [11]
RP   VARIANT EKD1 ARG-305.
RX   PubMed=22209761; DOI=10.1136/jmedgenet-2011-100653;
RA   Liu Q., Qi Z., Wan X.H., Li J.Y., Shi L., Lu Q., Zhou X.Q., Qiao L.,
RA   Wu L.W., Liu X.Q., Yang W., Liu Y., Cui L.Y., Zhang X.;
RT   "Mutations in PRRT2 result in paroxysmal dyskinesias with marked
RT   variability in clinical expression.";
RL   J. Med. Genet. 49:79-82(2012).
RN   [12]
RP   GENE FAMILY.
RX   PubMed=22363774; DOI=10.1371/journal.pone.0031961;
RA   Sallman Almen M., Bringeland N., Fredriksson R., Schioth H.B.;
RT   "The dispanins: a novel gene family of ancient origin that contains 14
RT   human members.";
RL   PLoS ONE 7:E31961-E31961(2012).
RN   [13]
RP   SUBCELLULAR LOCATION, AND CHARACTERIZATION OF VARIANT EKD1 CYS-308.
RX   PubMed=27172900; DOI=10.18632/oncotarget.9258;
RA   Liu Y.T., Nian F.S., Chou W.J., Tai C.Y., Kwan S.Y., Chen C., Kuo P.W.,
RA   Lin P.H., Chen C.Y., Huang C.W., Lee Y.C., Soong B.W., Tsai J.W.;
RT   "PRRT2 mutations lead to neuronal dysfunction and neurodevelopmental
RT   defects.";
RL   Oncotarget 7:39184-39196(2016).
RN   [14]
RP   VARIANT EKD1 TRP-266.
RX   PubMed=22120146; DOI=10.1093/brain/awr289;
RA   Wang J.L., Cao L., Li X.H., Hu Z.M., Li J.D., Zhang J.G., Liang Y., San A.,
RA   Li N., Chen S.Q., Guo J.F., Jiang H., Shen L., Zheng L., Mao X., Yan W.Q.,
RA   Zhou Y., Shi Y.T., Ai S.X., Dai M.Z., Zhang P., Xia K., Chen S.D.,
RA   Tang B.S.;
RT   "Identification of PRRT2 as the causative gene of paroxysmal kinesigenic
RT   dyskinesias.";
RL   Brain 134:3493-3501(2011).
RN   [15]
RP   VARIANT BFIS2 GLU-323.
RX   PubMed=22623405; DOI=10.1002/humu.22126;
RA   Schubert J., Paravidino R., Becker F., Berger A., Bebek N., Bianchi A.,
RA   Brockmann K., Capovilla G., Bernardina B.D., Fukuyama Y., Hoffmann G.F.,
RA   Jurkat-Rott K., Antonnen A.K., Kurlemann G., Lehesjoki A.E.,
RA   Lehmann-Horn F., Mastrangelo M., Mause U., Muller S., Neubauer B., Pust B.,
RA   Rating D., Robbiano A., Ruf S., Schroeder C., Seidel A., Specchio N.,
RA   Stephani U., Striano P., Teichler J., Turkdogan D., Vigevano F., Viri M.,
RA   Bauer P., Zara F., Lerche H., Weber Y.G.;
RT   "PRRT2 Mutations are the major cause of benign familial infantile
RT   seizures.";
RL   Hum. Mutat. 33:1439-1443(2012).
RN   [16]
RP   VARIANTS EKD1 ARG-281; THR-287 AND CYS-308.
RX   PubMed=22131361; DOI=10.1136/jmedgenet-2011-100635;
RA   Li J., Zhu X., Wang X., Sun W., Feng B., Du T., Sun B., Niu F., Wei H.,
RA   Wu X., Dong L., Li L., Cai X., Wang Y., Liu Y.;
RT   "Targeted genomic sequencing identifies PRRT2 mutations as a cause of
RT   paroxysmal kinesigenic choreoathetosis.";
RL   J. Med. Genet. 49:76-78(2012).
CC   -!- FUNCTION: As a component of the outer core of AMPAR complex, may be
CC       involved in synaptic transmission in the central nervous system. In
CC       hippocampal neurons, in presynaptic terminals, plays an important role
CC       in the final steps of neurotransmitter release, possibly by regulating
CC       Ca(2+)-sensing. In the cerebellum, may inhibit SNARE complex formation
CC       and downregulate short-term facilitation.
CC       {ECO:0000250|UniProtKB:E9PUL5}.
CC   -!- SUBUNIT: Component of the outer core of AMPAR complex
CC       (PubMed:25915028). AMPAR complex consists of an inner core made of 4
CC       pore-forming GluA/GRIA proteins (GRIA1, GRIA2, GRIA3 and GRIA4) and 4
CC       major auxiliary subunits arranged in a twofold symmetry. One of the two
CC       pairs of distinct binding sites is occupied either by CNIH2, CNIH3 or
CC       CACNG2, CACNG3. The other harbors CACNG2, CACNG3, CACNG4, CACNG8 or
CC       GSG1L. This inner core of AMPAR complex is complemented by outer core
CC       constituents binding directly to the GluA/GRIA proteins at sites
CC       distinct from the interaction sites of the inner core constituents.
CC       Outer core constituents include at least PRRT1, PRRT2, CKAMP44/SHISA9,
CC       FRRS1L and NRN1. The proteins of the inner and outer core serve as a
CC       platform for other, more peripherally associated AMPAR constituents.
CC       Alone or in combination, these auxiliary subunits control the gating
CC       and pharmacology of the AMPAR complex and profoundly impact their
CC       biogenesis and protein processing (By similarity). Interacts with
CC       intersectin 1/ITSN1 (By similarity). Interacts with SNARE complex
CC       components, including SNAP25, STX1A, SYT1 and SYT2; this interaction
CC       may inhibit SNARE complex formation (PubMed:25915028, PubMed:22832103).
CC       {ECO:0000250|UniProtKB:E9PUL5, ECO:0000269|PubMed:22832103,
CC       ECO:0000269|PubMed:25915028}.
CC   -!- INTERACTION:
CC       Q7Z6L0; Q13520: AQP6; NbExp=3; IntAct=EBI-722696, EBI-13059134;
CC       Q7Z6L0; Q9NZD1: GPRC5D; NbExp=3; IntAct=EBI-722696, EBI-13067820;
CC       Q7Z6L0; Q5SR56: MFSD14B; NbExp=3; IntAct=EBI-722696, EBI-373355;
CC       Q7Z6L0; Q3KNW5: SLC10A6; NbExp=3; IntAct=EBI-722696, EBI-18159983;
CC       Q7Z6L0; Q71RC9: SMIM5; NbExp=3; IntAct=EBI-722696, EBI-12334905;
CC       Q7Z6L0; Q96MV1: TLCD4; NbExp=3; IntAct=EBI-722696, EBI-12947623;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:22101681,
CC       ECO:0000269|PubMed:25915028, ECO:0000269|PubMed:27172900}; Single-pass
CC       membrane protein {ECO:0000250|UniProtKB:E9PUL5}. Cell junction,
CC       synapse, presynaptic cell membrane {ECO:0000250|UniProtKB:E9PUL5};
CC       Single-pass membrane protein {ECO:0000250|UniProtKB:E9PUL5}. Cell
CC       junction, synapse {ECO:0000250|UniProtKB:E9PUL5}. Cell projection, axon
CC       {ECO:0000269|PubMed:22832103}. Cytoplasmic vesicle, secretory vesicle,
CC       synaptic vesicle membrane {ECO:0000250|UniProtKB:D3ZFB6}. Cell
CC       junction, synapse, postsynaptic density membrane
CC       {ECO:0000250|UniProtKB:D3ZFB6}. Cell projection, dendritic spine
CC       {ECO:0000250|UniProtKB:D3ZFB6}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q7Z6L0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z6L0-2; Sequence=VSP_028815;
CC       Name=3;
CC         IsoId=Q7Z6L0-3; Sequence=VSP_028814;
CC   -!- DISEASE: Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]: An
CC       autosomal dominant neurologic condition characterized by recurrent and
CC       brief attacks of abnormal involuntary movements, triggered by sudden
CC       voluntary movement. These attacks usually have onset during childhood
CC       or early adulthood and can involve dystonic postures, chorea, or
CC       athetosis. {ECO:0000269|PubMed:22101681, ECO:0000269|PubMed:22120146,
CC       ECO:0000269|PubMed:22131361, ECO:0000269|PubMed:22209761,
CC       ECO:0000269|PubMed:25915028, ECO:0000269|PubMed:27172900}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry. Disease-causing mutations that produce truncation of the C-
CC       terminus of the protein alter subcellular location, from plasma
CC       membrane to cytoplasm (PubMed:22101681). {ECO:0000269|PubMed:22101681}.
CC   -!- DISEASE: Convulsions, familial infantile, with paroxysmal
CC       choreoathetosis (ICCA) [MIM:602066]: A syndrome characterized by
CC       clinical features of benign familial infantile seizures and episodic
CC       kinesigenic dyskinesia. Benign familial infantile seizures is a
CC       disorder characterized by afebrile seizures occurring during the first
CC       year of life, without neurologic sequelae. Paroxysmal choreoathetosis
CC       is a disorder of involuntary movements characterized by attacks that
CC       occur spontaneously or are induced by a variety of stimuli.
CC       {ECO:0000269|PubMed:22243967, ECO:0000269|PubMed:22832103}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Seizures, benign familial infantile, 2 (BFIS2) [MIM:605751]: A
CC       form of benign familial infantile epilepsy, a neurologic disorder
CC       characterized by afebrile seizures occurring in clusters during the
CC       first year of life, without neurologic sequelae. BFIS2 inheritance is
CC       autosomal dominant. {ECO:0000269|PubMed:22243967,
CC       ECO:0000269|PubMed:22399141, ECO:0000269|PubMed:22623405}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the CD225/Dispanin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Proline-rich transmembrane protein 2 (PRRT2);
CC       Note=Leiden Open Variation Database (LOVD);
CC       URL="https://databases.lovd.nl/shared/genes/PRRT2";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK092265; BAC03843.1; -; mRNA.
DR   EMBL; AK074572; BAC11067.1; -; mRNA.
DR   EMBL; AK292393; BAF85082.1; -; mRNA.
DR   EMBL; AL834185; CAD38881.1; -; mRNA.
DR   EMBL; CH471238; EAW79991.1; -; Genomic_DNA.
DR   EMBL; BC011405; AAH11405.1; -; mRNA.
DR   EMBL; BC053594; AAH53594.1; -; mRNA.
DR   CCDS; CCDS10654.1; -. [Q7Z6L0-1]
DR   CCDS; CCDS58445.1; -. [Q7Z6L0-2]
DR   CCDS; CCDS58446.1; -. [Q7Z6L0-3]
DR   RefSeq; NP_001243371.1; NM_001256442.1. [Q7Z6L0-2]
DR   RefSeq; NP_001243372.1; NM_001256443.1. [Q7Z6L0-3]
DR   RefSeq; NP_660282.2; NM_145239.2. [Q7Z6L0-1]
DR   RefSeq; XP_011544017.1; XM_011545715.2. [Q7Z6L0-2]
DR   RefSeq; XP_011544018.1; XM_011545716.2.
DR   RefSeq; XP_016878377.1; XM_017022888.1. [Q7Z6L0-1]
DR   BioGRID; 125188; 16.
DR   IntAct; Q7Z6L0; 15.
DR   MINT; Q7Z6L0; -.
DR   STRING; 9606.ENSP00000456226; -.
DR   TCDB; 8.A.58.2.1; the dispanin (dispanin) family.
DR   iPTMnet; Q7Z6L0; -.
DR   PhosphoSitePlus; Q7Z6L0; -.
DR   BioMuta; PRRT2; -.
DR   DMDM; 74738828; -.
DR   MassIVE; Q7Z6L0; -.
DR   PaxDb; Q7Z6L0; -.
DR   PeptideAtlas; Q7Z6L0; -.
DR   PRIDE; Q7Z6L0; -.
DR   ProteomicsDB; 69436; -. [Q7Z6L0-1]
DR   ProteomicsDB; 69437; -. [Q7Z6L0-2]
DR   ProteomicsDB; 69438; -. [Q7Z6L0-3]
DR   Antibodypedia; 3043; 100 antibodies.
DR   DNASU; 112476; -.
DR   Ensembl; ENST00000300797; ENSP00000300797; ENSG00000167371. [Q7Z6L0-3]
DR   Ensembl; ENST00000358758; ENSP00000351608; ENSG00000167371. [Q7Z6L0-1]
DR   Ensembl; ENST00000567659; ENSP00000456226; ENSG00000167371. [Q7Z6L0-2]
DR   Ensembl; ENST00000572820; ENSP00000458291; ENSG00000167371. [Q7Z6L0-1]
DR   Ensembl; ENST00000636131; ENSP00000490390; ENSG00000167371. [Q7Z6L0-3]
DR   Ensembl; ENST00000637064; ENSP00000490826; ENSG00000167371. [Q7Z6L0-1]
DR   Ensembl; ENST00000647876; ENSP00000498021; ENSG00000167371. [Q7Z6L0-3]
DR   GeneID; 112476; -.
DR   KEGG; hsa:112476; -.
DR   UCSC; uc002dud.4; human. [Q7Z6L0-1]
DR   CTD; 112476; -.
DR   DisGeNET; 112476; -.
DR   GeneCards; PRRT2; -.
DR   GeneReviews; PRRT2; -.
DR   HGNC; HGNC:30500; PRRT2.
DR   HPA; ENSG00000167371; Tissue enhanced (brain).
DR   MalaCards; PRRT2; -.
DR   MIM; 128200; phenotype.
DR   MIM; 602066; phenotype.
DR   MIM; 605751; phenotype.
DR   MIM; 614386; gene.
DR   neXtProt; NX_Q7Z6L0; -.
DR   OpenTargets; ENSG00000167371; -.
DR   Orphanet; 306; Benign familial infantile epilepsy.
DR   Orphanet; 569; Familial or sporadic hemiplegic migraine.
DR   Orphanet; 31709; Infantile convulsions and choreoathetosis.
DR   Orphanet; 98811; Paroxysmal exertion-induced dyskinesia.
DR   Orphanet; 98809; Paroxysmal kinesigenic dyskinesia.
DR   Orphanet; 98810; Paroxysmal non-kinesigenic dyskinesia.
DR   PharmGKB; PA142671132; -.
DR   VEuPathDB; HostDB:ENSG00000167371.16; -.
DR   eggNOG; ENOG502S2U1; Eukaryota.
DR   GeneTree; ENSGT00940000161103; -.
DR   HOGENOM; CLU_070349_0_0_1; -.
DR   InParanoid; Q7Z6L0; -.
DR   OMA; TKTHPAN; -.
DR   OrthoDB; 1101977at2759; -.
DR   PhylomeDB; Q7Z6L0; -.
DR   TreeFam; TF331357; -.
DR   PathwayCommons; Q7Z6L0; -.
DR   SignaLink; Q7Z6L0; -.
DR   BioGRID-ORCS; 112476; 4 hits in 988 CRISPR screens.
DR   ChiTaRS; PRRT2; human.
DR   GeneWiki; PRRT2; -.
DR   GenomeRNAi; 112476; -.
DR   Pharos; Q7Z6L0; Tbio.
DR   PRO; PR:Q7Z6L0; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q7Z6L0; protein.
DR   Bgee; ENSG00000167371; Expressed in right hemisphere of cerebellum and 112 other tissues.
DR   ExpressionAtlas; Q7Z6L0; baseline and differential.
DR   Genevisible; Q7Z6L0; HS.
DR   GO; GO:0043679; C:axon terminus; ISS:UniProtKB.
DR   GO; GO:0043197; C:dendritic spine; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0098839; C:postsynaptic density membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098793; C:presynapse; ISS:UniProtKB.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0008021; C:synaptic vesicle; ISS:UniProtKB.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031982; C:vesicle; ISS:UniProtKB.
DR   GO; GO:0017075; F:syntaxin-1 binding; ISS:UniProtKB.
DR   GO; GO:1905513; P:negative regulation of short-term synaptic potentiation; ISS:UniProtKB.
DR   GO; GO:0035544; P:negative regulation of SNARE complex assembly; ISS:UniProtKB.
DR   GO; GO:0050884; P:neuromuscular process controlling posture; IMP:MGI.
DR   GO; GO:0031629; P:synaptic vesicle fusion to presynaptic active zone membrane; ISS:UniProtKB.
DR   InterPro; IPR007593; CD225/Dispanin_fam.
DR   Pfam; PF04505; CD225; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell junction; Cell membrane; Cell projection;
KW   Cytoplasmic vesicle; Disease variant; Dystonia; Epilepsy; Membrane;
KW   Methylation; Phosphoprotein; Postsynaptic cell membrane;
KW   Reference proteome; Synapse; Transmembrane; Transmembrane helix.
FT   CHAIN           1..340
FT                   /note="Proline-rich transmembrane protein 2"
FT                   /id="PRO_0000307745"
FT   TOPO_DOM        1..268
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5, ECO:0000255"
FT   INTRAMEM        269..289
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5, ECO:0000255"
FT   TOPO_DOM        290..317
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5, ECO:0000255"
FT   TRANSMEM        318..338
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5, ECO:0000255"
FT   TOPO_DOM        339..340
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5, ECO:0000255"
FT   COMPBIAS        131..216
FT                   /note="Pro-rich"
FT   MOD_RES         28
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5"
FT   MOD_RES         74
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5"
FT   MOD_RES         238
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:D3ZFB6"
FT   MOD_RES         240
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5"
FT   MOD_RES         248
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5"
FT   MOD_RES         249
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:E9PUL5"
FT   VAR_SEQ         294..340
FT                   /note="SRNSLQQGDVDGAQRLGRVAKLLSIVALVGGVLIIIASCVINLGVYK -> V
FT                   SPMGP (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_028814"
FT   VAR_SEQ         337
FT                   /note="G -> GGEWGLGTGRGGMEGLARAALLTPAPALSCLSSLPLLCLSLSPPPPV
FT                   CPSLSSPT (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:16303743"
FT                   /id="VSP_028815"
FT   VARIANT         138
FT                   /note="P -> A (in dbSNP:rs79182085)"
FT                   /evidence="ECO:0000269|PubMed:22101681"
FT                   /id="VAR_067010"
FT   VARIANT         147
FT                   /note="D -> H (in dbSNP:rs79568162)"
FT                   /evidence="ECO:0000269|PubMed:22101681"
FT                   /id="VAR_067011"
FT   VARIANT         214
FT                   /note="A -> P (in dbSNP:rs745594874)"
FT                   /evidence="ECO:0000269|PubMed:22101681"
FT                   /id="VAR_067012"
FT   VARIANT         215
FT                   /note="P -> R (in dbSNP:rs200926711)"
FT                   /evidence="ECO:0000269|PubMed:22243967"
FT                   /id="VAR_067320"
FT   VARIANT         216
FT                   /note="P -> L (in dbSNP:rs76335820)"
FT                   /evidence="ECO:0000269|PubMed:22243967"
FT                   /id="VAR_067321"
FT   VARIANT         237
FT                   /note="G -> R (in dbSNP:rs199556853)"
FT                   /evidence="ECO:0000269|PubMed:22101681"
FT                   /id="VAR_067013"
FT   VARIANT         240..340
FT                   /note="Missing (in ICCA; may be produced at very low levels
FT                   due to a premature stop codon in the mRNA, that could lead
FT                   to nonsense-mediated mRNA decay; dbSNP:rs387907126)"
FT                   /evidence="ECO:0000269|PubMed:22832103"
FT                   /id="VAR_080269"
FT   VARIANT         245
FT                   /note="R -> H (in dbSNP:rs754897123)"
FT                   /evidence="ECO:0000269|PubMed:22101681"
FT                   /id="VAR_067014"
FT   VARIANT         266
FT                   /note="R -> W (in EKD1; dbSNP:rs387907128)"
FT                   /evidence="ECO:0000269|PubMed:22120146"
FT                   /id="VAR_067322"
FT   VARIANT         281
FT                   /note="W -> R (in EKD1)"
FT                   /evidence="ECO:0000269|PubMed:22131361"
FT                   /id="VAR_067323"
FT   VARIANT         287
FT                   /note="A -> T (in EKD1; may affect subcellular location,
FT                   becoming predominantly cytoplasmic; impairs interaction
FT                   with GRIA1 and SNAP25)"
FT                   /evidence="ECO:0000269|PubMed:22131361,
FT                   ECO:0000269|PubMed:25915028"
FT                   /id="VAR_067324"
FT   VARIANT         305
FT                   /note="G -> R (in EKD1; dbSNP:rs767799831)"
FT                   /evidence="ECO:0000269|PubMed:22209761"
FT                   /id="VAR_067325"
FT   VARIANT         308
FT                   /note="R -> C (in EKD1; no effect on location at the plasma
FT                   membrane; dbSNP:rs932713001)"
FT                   /evidence="ECO:0000269|PubMed:22131361,
FT                   ECO:0000269|PubMed:27172900"
FT                   /id="VAR_067326"
FT   VARIANT         317
FT                   /note="S -> N (in ICCA; dbSNP:rs387907125)"
FT                   /evidence="ECO:0000269|PubMed:22243967"
FT                   /id="VAR_067327"
FT   VARIANT         323
FT                   /note="G -> E (in BFIS2)"
FT                   /evidence="ECO:0000269|PubMed:22623405"
FT                   /id="VAR_068426"
FT   CONFLICT        151
FT                   /note="T -> S (in Ref. 5; AAH11405)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        214
FT                   /note="A -> AP (in Ref. 3; CAD38881)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        275
FT                   /note="S -> P (in Ref. 3; CAD38881)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   340 AA;  34945 MW;  F4BBA6559F081E34 CRC64;
     MAASSSEISE MKGVEESPKV PGEGPGHSEA ETGPPQVLAG VPDQPEAPQP GPNTTAAPVD
     SGPKAGLAPE TTETPAGASE TAQATDLSLS PGGESKANCS PEDPCQETVS KPEVSKEATA
     DQGSRLESAA PPEPAPEPAP QPDPRPDSQP TPKPALQPEL PTQEDPTPEI LSESVGEKQE
     NGAVVPLQAG DGEEGPAPEP HSPPSKKSPP ANGAPPRVLQ QLVEEDRMRR AHSGHPGSPR
     GSLSRHPSSQ LAGPGVEGGE GTQKPRDYII LAILSCFCPM WPVNIVAFAY AVMSRNSLQQ
     GDVDGAQRLG RVAKLLSIVA LVGGVLIIIA SCVINLGVYK
//
